Bringing to Market: Skin-to-Thing Technology
2021-09-28T12:30:00 2021-09-28T12:30:00 - 2021-09-28T13:00:00
New approaches to drug delivery are a fast-growing field in the medical device industry. Strong market forces and healthcare trends are dramatically enhancing this evolution. Pharmacological advancements in drugs developments and their manufacturing, have a tremendous contribution to the drug delivery field. One meaningful drive is the significant rise of injectable biologic therapies for more and more chronic conditions. The challenges presented by these drugs, are creating the need and opportunity for drug delivery systems.
The personalised medicine trend is obviously influencing drug related topics. The changes in approach to the patient are shifting hospital care to homecare setting, and simultaneously, shifting administrating injection of drugs subcutaneously instead of intravenous. Obviously intravenous injection demands costly skilled staff and mostly cannot be done in home setting. These are all taking part too in the evolution of drug delivery devices.
Another meaningful factor is patient's non-compliance to treatment, which is not only affecting the patient's health and poor outcomes but is also baring substantial losses to pharmaceutical companies and resulting in a serious burden to the healthcare system. We are, therefore, witnessing a great interest in adequate solutions for wearable drug delivery advanced devices which adhere to the patient's skin.
When designing such a system, some significant challenges arise. The development of a drug delivery patch device involves critical issues such as safety, the drug/reservoir interaction and many other elements which are necessary to be considered. However, engineering teams are becoming more and more familiar with yet another critical aspect -human factor and ergonomics. These factors are most crucial with any S2T (‘Skin to Thing’) solution and have an even more crucial weight when dealing with a drug delivery patch pump.
The ‘Skin-to-Thing’ medical patch which is required to adhere the device to the body is indeed the body/machine crucial interface and should be given just as much a careful and thorough attention as the device itself, in order to achieve the device goals, assure the patient's compliance and successful treatment.
Med-Tech gives us the opportunity to show and discuss the types of services that Boddingtons Plastics can offer to our customers. We've seen really good footfall and had several new leads for new devices. The show has been a great success for us and in fact we've booked for next year already.
MedTech Innovation Expo was a fascinating event that gave us new insight and inspiration into the challenges we face and, more importantly, into the solutions to solve those challenges. We’ve already marked the event on our calendar for next year and we can’t wait to see what progress has been made… and perhaps, more importantly, what progress we can aid with our Aether Engine technology!
It was great to speak at this excellent event, very well attended by the NHS and Industry, well organised and plenty of opportunities for networking. Looking forward to coming again next year!
We’ve managed to get a lot of interest of people... It’s a lot bigger than what we expected, and we’ve managed to find unexpected partnerships with companies we didn’t even know existed. We were here last year but we weren’t exhibiting, and we were impressed with the quality and quantity of exhibitors, so we thought it was worth it this year.